(c) 2024 PillSync.com

12 HR Acetazolamide 500 MG Extended Release Oral Capsule

INDICATIONS AND USAGE: For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide extended-release capsules are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness despite gradual ascent.

Cadila Healthcare Limited


4 years ago CAPSULE YELLOW XYL 34 12 HR Acetazolamide 500 MG Extended Release Oral Capsule

CAPSULE YELLOW XYL 34

HOW SUPPLIED:

ACETAZOLAMIDE Extended-release capsules, USP 500 mg are white to off white pellets filled in size "00el" empty hard gelatin capsules with opaque yellow colored cap imprinted with "XYL" in black ink and opaque white colored body imprinted with "34" in black ink and are supplied as follows: NDC 65841-762-06 in bottles of 30 capsules with child-resistant closure NDC 65841-762-16 in bottles of 90 capsules with child-resistant closure NDC 65841-762-01 in bottles of 100 capsules with child-resistant closure NDC 65841-762-05 in bottles of 500 capsules NDC 65841-762-10 in bottles of 1000 capsules NDC 65841-762-30 in unit-dose blister cartons of 100 (10 x 10) unit-dose capsules Storage Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] . Dispense in a tight container (USP). Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India Rev.: 02/24


More pills like CAPSULE XYL 34












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site